Here's Shouldn'T Asana: Why You Shouldn't Buy the Dip
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesAsana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Oil tensions linked to Iran have put pressure on stocks, lifting energy prices and weighing on the S&P 500 and Nasdaq...
An institutional liquidation shook MTN shares as MSA Advisors exited its Vail Resorts stake. This analysis explains t...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
An insider move of 8,000 shares can raise questions for investors. This article breaks down what such a sale might si...
A high-earning investor can leverage oil well tax rules to dramatically reduce first-year tax bills, even as energy m...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Berkshire Hathaway just repurchased stock, signaling a shift in how the company’s massive cash pile may be deployed. ...